Clinical Trial Update: A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics [Phase 1]

View source ↗

Summary

A Phase 1 pediatric trial sponsored by GlaxoSmithKline to evaluate an antibacterial therapy for urinary tract infections in children aged 2 to under 12; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Snippet

Sponsor: GlaxoSmithKline | Conditions: Urinary Tract Infections | Phase 1 | Status: NOT_YET_RECRUITING